JPMorgan plans autocallable securities linked to GW Pharmaceuticals

By Marisa Wong

Morgantown, W.Va., Dec. 28 – JPMorgan Chase Financial Co. LLC plans to price 0% autocallable securities due Jan. 3, 2020 linked to the American Depositary Shares of GW Pharmaceuticals plc, according to a 424B2 filing with the Securities and Exchange Commission.

The notes are guaranteed by JPMorgan Chase & Co.

The notes will be automatically called at par plus an early redemption premium of at least 10.15% per year if the stock closes at or above 90% of its initial price on any quarterly determination date. The exact call premium will be set at pricing.

If the notes have not been called and the final share price is at least 90% of the initial price, the payout at maturity will be par plus a return of at least 10.15% per year, or at least $13.045 per $10 principal amount. Otherwise, investors will be fully exposed to the share price decline.

J.P. Morgan Securities LLC is the agent with Morgan Stanley Wealth Management handling distribution.

The notes will price on Dec. 29.

The Cusip number is 48128P399.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.